Clinical Trial Detail

NCT ID NCT04046445
Title Phase 1b Study to Evaluate ATP128, With or Without BI 754091, in Patients With Stage IV Colorectal Cancer (KISIMA-01)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Amal Therapeutics
Indications

colorectal cancer

Therapies

ATP128 + BI 754091

ATP128

Age Groups: senior adult

No variant requirements are available.